Caption Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.75M Sell
9,700
-6,800
-41% -$2.52M 0.02% 677
2026
Q1
$4.83M Buy
16,500
+9,000
+120% +$2.96M 0.03% 542
2025
Q4
$2.63M Hold
7,500
0.02% 741
2025
Q3
$2.42M Buy
+7,500
New +$2.33M 0.02% 769
2025
Q1
Sell
-10,000
Closed -$3.69M 1658
2024
Q4
$3.69M Buy
+10,000
New +$4.18M 0.03% 474
2024
Q3
Sell
-16,000
Closed -$8.67M 1372
2024
Q2
$8.67M Buy
+16,000
New +$8.46M 0.13% 167
2020
Q3
Sell
-25,000
Closed -$6.58M 1087
2020
Q2
$6.58M Buy
+25,000
New +$6.67M 0.22% 123

Other funds holding ELV

Caption Management's ELV Position: Q2 2026 in Review

Caption Management sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 6,400 shares — an estimated $2.37M sold.

Caption Management first reported a position in ELV in Q2 2020 and held it in 6 quarters. The position peaked at $5M in Q2 2020. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Caption Management reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Caption Management sold 6,400 Elevance Health shares in Q2 2026, an estimated $2.37M.
  • Caption Management first reported a position in Elevance Health in Q2 2020 and held it in 6 quarters.
  • Caption Management's Elevance Health position peaked at $5M in Q2 2020.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.